During the first two years of Horizon 2020 (Work Programme for 2014/15), the EU will invest some €1 200 million in this Challenge.
Research & Innovation supported by this call will:
R&I supported by this call will leverage Member State activities in areas including neuroscience, cancer, systems medicine. It will contribute to European and international initiatives such as the European Innovation Partnership on Active and Healthy Ageing, the Global Alliance for Chronic Diseases, the Joint Programming Initiative "More Years, Better Lives - the Challenges and Opportunities of Demographic Change" and the Joint Programming on Neurodegenerative Diseases Research.
Several activities not included in the 2014/15 work programme will also be part of the 'Health, demographic change and wellbeing' challenge, notably the Innovative Medicines Initiative, the European and Developing Countries Clinical Trials Partnership (EDCTP), and the Active and Assisted Living Programme.
The Scientific Panel for Health is a science-led expert panel, whose role will be to:
This €1 million challenge prize addresses the issue of the unnecessary use of antibiotics, which is contributing to the growing problem of antibiotic resistance. The challenge is to develop a rapid test that will allow healthcare providers to distinguish at the point of care between patients with upper respiratory tract infections that require antibiotics and those that can be treated safely without antibiotics.
R&I supported by this societal challenge will enable the translation of findings from the laboratory into the clinic and other health and care settings, by engaging all relevant R&I performers. For instance,